Concert Genetics is pleased to offer this in-depth report covering the genetic testing marketplace. Key points addressed in this document include:
1. Market Size
There are almost 70,000 genetic testing products on the US market.
2. Market Growth
An average of approximately 10 new testing products enter the market every day, making it difficult for stakeholders across the healthcare system to manage the pace of change.
3. Next Generation Sequencing
Much of the growth in the market is attributable to NextGen Sequencing (NGS), which now accounts for an estimated 48% of the tests currently on the market.
4. Complexity and Variety
Testing options are becoming more complex, with laboratories packaging testing products in a widening variety of ways. BRCA1/2 , Exome and Non-invasive Prenatal Testing (NIPT), specifically, are available in increasing variety.
5. Clinical Workflow
Healthcare providers face mounting challenges integrating genetic testing into the clinical workflow. Utilization management tools, such as the Concert Platform, are helping institutions across the country address and overcome these challenges.
Submit the form on this page for instant access to the report.